Global and United States Gastrointestinal Stromal Tumor (GIST) Drug Market Industry Analysis, Size, Share, Growth, Trends and Forecast, 2018-2025 by Global QYResearch

By | March 27, 2018

The new research from Global QYResearch on Global and United States Gastrointestinal Stromal Tumor (GIST) Drug Market Report for 2018 intends to offer target audience with the fresh outlook on market and fill in the knowledge gaps with the help of processed information and opinions from industry experts. The information in the research report is well-processed and a report is accumulated by industry professionals and seasoned experts in the field to ensure of the quality of research.

Download Sample Report Copy From Herehttp://globalqyresearch.com/download-sample/423926

The research is backed by extensive and in-depth secondary research which involves reference to various statistical databases, national government documents, relevant patent and regulatory databases, news articles, press releases, company annual reports, webcasts, financial reports, and a number of internal and external proprietary databases. This estimated data is cross-checked with industry experts from various leading companies in the market. After the entire authentication process, these reports are shared with subject matter experts (SMEs) for adding further value and to gain their insightful opinion on the research. With such robust process of data extraction, verification, and finalization, we firmly endorse the quality of our research. With such extensive and in-depth research and comprehensive coverage of information, it is always a possibility of clients finding their desired information in the report with enclosure of key components and valuable statistics in all regards.

The Global and United States Gastrointestinal Stromal Tumor (GIST) Drug Market report contains a complete industry overview to provide clients with a holistic idea of market situation and its tendencies. The comprehensive view of the research is followed by segmentation, application, and regional analysis of the market to ensure that clients are well conversant about each section. The report also covers key pointers and facts of Global and United States Gastrointestinal Stromal Tumor (GIST) Drug Market in terms of its sales and growth.

One of the major mainstays of Global and United States Gastrointestinal Stromal Tumor (GIST) Drug Market report is the coverage of competition. The report covers the key competition parameters such as share of competitors, their segmental revenues, product development and marketing strategies, and R&D along with the general contact information. Also, the high level analysis such as cost analysis, sourcing strategy, industry chain analysis, distributors, marketing strategy, and factor analysis for Global and United States Gastrointestinal Stromal Tumor (GIST) Drug Market all covered under the report scope.

With every published report, it has always been the objective of Global QYResearch to offer the complete and true market information to the buyers and assist them in their decision making. Irrespective of the interest, academic or commercial, the Global and United States Gastrointestinal Stromal Tumor (GIST) Drug Market designed and amassed by our subject matter experts will definitely shed light on key information aspired by the clients.

Reasons to Buy this Report

The research report will enrich your decision-making capability by helping you to –

  • Design and improve your product development and sales strategies and enhancing your marketing activities
  • Develop business strategies by understanding the market dynamics and developments driving the Global and United States Gastrointestinal Stromal Tumor (GIST) Drug Marketx market
  • Develop market-entry strategies and effective ways to sustain competition
  • Create merger and acquisition opportunities by identifying the market players with the most innovative pipelines
  • Identify the regional market potential which would further help in designing regional market strategies
  • Understand the competitive scenario in the Global and United States Gastrointestinal Stromal Tumor (GIST) Drug Marketx market
  • Take more informed business decisions by relying on the insightful opinions from industry experts

Why Global QY Research ?

  • Technically acclaimed Analysts with complete industry knowhow
  • Robust research methodology followed by our publishers to arrive at market estimates
  • Focus on technology trends
  • Extensive repository of market research reports to meet our client’s needs
  • Based on extensive research, we provide clear view of real market scenario and help clients with making informed business decisions

Ask Query Here:Jay@globalqyresearch.com or Sales@globalqyresearch.com

Table of Contents

2018-2025 Gastrointestinal Stromal Tumor (GIST) Drug Report on Global and United States Market, Status and Forecast, by Players, Types and Applications

1 Methodology and Data Source
1.1 Methodology/Research Approach
1.1.1 Research Programs/Design
1.1.2 Market Size Estimation
1.1.3 Market Breakdown and Data Triangulation
1.2 Data Source
1.2.1 Secondary Sources
1.2.2 Primary Sources
1.3 Disclaimer

2 Gastrointestinal Stromal Tumor (GIST) Drug Market Overview
2.1 Gastrointestinal Stromal Tumor (GIST) Drug Product Overview
2.2 Gastrointestinal Stromal Tumor (GIST) Drug Market Segment by Type
2.2.1 Amcasertib
2.2.2 Anagrelide hydrochloride CR
2.2.3 APG-1351
2.2.4 Binimetinib
2.2.5 Others
2.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Product Segment by Type
2.3.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) and Growth (%) by Type (2013, 2017 and 2025)
2.3.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) and Market Share (%) by Type (2013-2018)
2.3.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Million USD) and Market Share (%) by Type (2013-2018)
2.3.4 Global Gastrointestinal Stromal Tumor (GIST) Drug Price (USD/Pcs) by Type (2013-2018)
2.4 United States Gastrointestinal Stromal Tumor (GIST) Drug Product Segment by Type
2.4.1 United States Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) and Growth by Type (2013, 2017 and 2025)
2.4.2 United States Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) and Market Share by Type (2013-2018)
2.4.3 United States Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Million USD) and Market Share by Type (2013-2018)
2.4.4 United States Gastrointestinal Stromal Tumor (GIST) Drug Price (USD/Pcs) by Type (2013-2018)

3 Gastrointestinal Stromal Tumor (GIST) Drug Application/End Users
3.1 Gastrointestinal Stromal Tumor (GIST) Drug Segment by Application/End Users
3.1.1 Clinic
3.1.2 Hospital
3.1.3 Others
3.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Product Segment by Application
3.2.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) and CGAR (%) by Application (2013, 2017 and 2025)
3.2.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) and Market Share (%) by Application (2013-2018)
3.3 United States Gastrointestinal Stromal Tumor (GIST) Drug Product Segment by Application
3.3.1 United States Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) and CGAR (%) by Application (2013, 2017 and 2025)
3.3.2 United States Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) and Market Share (%) by Application (2013-2018)

4 Gastrointestinal Stromal Tumor (GIST) Drug Market Status and Outlook by Regions
4.1 Global Market Status and Outlook by Regions
4.1.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size and CAGR by Regions (2013, 2017 and 2025)
4.1.2 North America
4.1.3 Asia-Pacific
4.1.4 Europe
4.1.5 South America
4.1.6 Middle East and Africa
4.1.7 United States
4.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales and Revenue by Regions
4.2.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) and Market Share (%) by Regions (2013-2018)
4.2.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Million USD) and Market Share (%) by Regions (2013-2018)
4.2.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
4.2.4 North America Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
4.2.5 Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
4.2.6 Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
4.2.7 South America Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
4.2.8 Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
4.2.9 United States Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)

5 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Competition by Players/Manufacturers
5.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) and Market Share by Players (2013-2018)
5.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Million USD) and Share by Players (2013-2018)
5.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Average Price (USD/Pcs) by Players (2013-2018)
5.4 Global Top Players Gastrointestinal Stromal Tumor (GIST) Drug Manufacturing Base Distribution, Sales Area, Product Types
5.5 Gastrointestinal Stromal Tumor (GIST) Drug Market Competitive Situation and Trends
5.5.1 Gastrointestinal Stromal Tumor (GIST) Drug Market Concentration Rate
5.5.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Share (%) of Top 3 and Top 5 Players
5.5.3 Mergers & Acquisitions, Expansion

6 United States Gastrointestinal Stromal Tumor (GIST) Drug Market Competition by Players/Manufacturers
6.1 United States Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) and Market Share by Players (2013-2018)
6.2 United States Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Million USD) and Share by Players (2013-2018)
6.3 United States Gastrointestinal Stromal Tumor (GIST) Drug Average Price (USD/Pcs) by Players (2013-2018)
6.4 United States Gastrointestinal Stromal Tumor (GIST) Drug Market Share (%) of Top 3 and Top 5 Players

7 Gastrointestinal Stromal Tumor (GIST) Drug Players/Manufacturers Profiles and Sales Data
7.1 Ariad Pharmaceuticals, Inc.
7.1.1 Company Basic Information, Manufacturing Base and Competitors
7.1.2 Gastrointestinal Stromal Tumor (GIST) Drug Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
7.1.4 Main Business/Business Overview
7.2 Arog Pharmaceuticals, Inc.
7.2.1 Company Basic Information, Manufacturing Base and Competitors
7.2.2 Gastrointestinal Stromal Tumor (GIST) Drug Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
7.2.4 Main Business/Business Overview
7.3 Array BioPharma Inc.
7.3.1 Company Basic Information, Manufacturing Base and Competitors
7.3.2 Gastrointestinal Stromal Tumor (GIST) Drug Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
7.3.4 Main Business/Business Overview
7.4 Astex Pharmaceuticals, Inc.
7.4.1 Company Basic Information, Manufacturing Base and Competitors
7.4.2 Gastrointestinal Stromal Tumor (GIST) Drug Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
7.4.4 Main Business/Business Overview
7.5 Blueprint Medicines Corporation
7.5.1 Company Basic Information, Manufacturing Base and Competitors
7.5.2 Gastrointestinal Stromal Tumor (GIST) Drug Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
7.5.4 Main Business/Business Overview
7.6 Boston Biomedical, Inc.
7.6.1 Company Basic Information, Manufacturing Base and Competitors
7.6.2 Gastrointestinal Stromal Tumor (GIST) Drug Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
7.6.4 Main Business/Business Overview
7.7 Calithera Biosciences, Inc.
7.7.1 Company Basic Information, Manufacturing Base and Competitors
7.7.2 Gastrointestinal Stromal Tumor (GIST) Drug Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
7.7.4 Main Business/Business Overview
7.8 Chipscreen Biosciences Ltd
7.8.1 Company Basic Information, Manufacturing Base and Competitors
7.8.2 Gastrointestinal Stromal Tumor (GIST) Drug Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
7.8.4 Main Business/Business Overview
7.9 Deciphera Pharmaceuticals, LLC
7.9.1 Company Basic Information, Manufacturing Base and Competitors
7.9.2 Gastrointestinal Stromal Tumor (GIST) Drug Product Category, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
7.9.4 Main Business/Business Overview
7.10 F. Hoffmann-La Roche Ltd.
7.10.1 Company Basic Information, Manufacturing Base and Competitors
7.10.2 Gastrointestinal Stromal Tumor (GIST) Drug Product Category, Application and Specification
7.10.2.1 Product A
7.10.2.2 Product B
7.10.3 F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
7.10.4 Main Business/Business Overview
7.11 Horizon Pharma Plc
7.12 Immunicum AB
7.13 Jiangsu Hengrui Medicine Co., Ltd.
7.14 Kolltan Pharmaceuticals, Inc.
7.15 Natco Pharma Limited
7.16 Nerviano Medical Sciences S.r.l.
7.17 Novartis AG
7.18 Omeros Corporation

8 Gastrointestinal Stromal Tumor (GIST) Drug Manufacturing Cost, Industrial Chain and Downstream Buyers
8.1 Gastrointestinal Stromal Tumor (GIST) Drug Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Gastrointestinal Stromal Tumor (GIST) Drug Industrial Chain Analysis
8.4 Downstream Buyers in United States

9 Marketing Strategy Analysis, Distributors and Market Effect Factors
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Distributors in Untied States
9.3 Market Effect Factors Analysis
9.3.1 Economic/Political Environmental Change
9.3.2 Downstream Demand Change
9.3.3 Technology Progress in Related Industry
9.3.4 Substitutes Threat

10 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Forecast
10.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue Forecast (2018-2025)
10.1.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
10.1.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
10.2 United States Gastrointestinal Stromal Tumor (GIST) Drug Market Forecast
10.2.1 United States Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
10.2.2 United States Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
10.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Forecast by Regions
10.3.1 North America Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
10.3.2 Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
10.3.3 Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
10.3.4 South America Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
10.3.5 Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
10.4 Gastrointestinal Stromal Tumor (GIST) Drug Forecast by Type
10.4.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) and Revenue (Million USD) Forecast by Type (2018-2025)
10.4.2 United States Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) and Revenue (Million USD) Forecast by Type (2018-2025)
10.5 Gastrointestinal Stromal Tumor (GIST) Drug Forecast by Application
10.5.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) Forecast by Application (2018-2025)
10.5.2 United States Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) Forecast by Application (2018-2025)

11 Research Findings and Conclusion

The report is readily available and can be dispatched within 4hr after payment confirmation.

To Purchase this Premium Report: http://globalqyresearch.com/checkout-form/0/423926

Leave a Reply

Your email address will not be published. Required fields are marked *